Facing two life-threatening diagnoses, I overcame fear of self-injections by leaning on love, encouragement and determination ...

NHS England now offers the "Trojan horse" therapy, belantamab mafodotin (Blenrep) for patients with multiple myeloma.

Treating types of cancer with CAR T-cell therapy is expensive and inconvenient, but a streamlined approach that creates the ...

The NHS in England will be the first health system in the world to roll-out a ‘trojan horse’ targeted therapy for blood cancer patients which could halt the disease’s progression by nearly three times ...

But a new drug from Protagonist Therapeutics and Takeda can slow down a patient’s production of red blood cells and nearly ...

The space environment is not kind to human bodies. The final frontier may therefore be the perfect place to study cancer — ...

A Sheffield man has become one of the first patients in the world to benefit from a pioneering therapy that could halt the ...

The new study aimed to treat solid tumors like blood cancer—with a single injection into a patient’s vein. The team engineered CAR T cells that could hunt down metastasized cancer cells. When infused ...

Campbell has had a well-documented, and long, battle with cancer.

The US-based biotech company has submitted an application to the Saudi Food and Drug Authority (SFDA) for Breakthrough ...

I got breast cancer at 30. Now, because of my treatment, I have to wait 5 to 10 years to have kids, and I'm mourning the ...

FDA granted priority review to Zepzelca plus Tecentriq for first-line maintenance in extensive-stage small cell lung cancer.